After FDA setback, psychedelic drugmakers distance themselves from a pioneer The Washington Postsource Post navigation Use Of Psilocybin For Mental Health Treatment 'Not Associated' With Risk Of Paranoia, American Medical Association Study Finds – Marijuana MomentMeet the Citizen Scientists Who Think Mushrooms Have Superpowers – The Cut
